Conversely, PD-1 signaling, a major pathway protecting against CNS inflammation in MCAO, likely plays a crucial role in reducing stroke-associated TLR2- and TLR4-mediated neurotoxic factor release by activated CNS microglia [44]. Here, TLR2 is linked to stroke disorder.